Leapfrog Acquisition Corporation (NASDAQ:LFACU) Closes $143.75 Million IPO

SUMMIT, N.J. — December 10, 2025 — Leads & Copy — Leapfrog Acquisition Corporation has closed its initial public offering (IPO) of 14,375,000 units, including the underwriter’s full exercise of their over-allotment option to purchase 1,875,000 units. The offering was priced at $10.00 per unit, resulting in gross proceeds of $143,750,000.

The units began trading on the Global Market tier of The Nasdaq Stock Market LLC on December 5, 2025, under the symbol LFACU.

Leapfrog Acquisition Corporation, led by Matthew R. Pollard, Abhay N. Pande, and Kevin M. Murphy, is a special purpose acquisition company (SPAC) created to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.

Each unit in the offering consists of one Class A ordinary share and one-half of one redeemable warrant. The warrants have a strike price of $11.50 per ordinary share and are exercisable within five years of the company completing an initial business combination.

It is anticipated that once the securities begin separate trading, the ordinary shares and warrants will be listed on the Global Market tier of The Nasdaq Stock Market LLC under the symbols “LFAC” and “LFACW,” respectively.

BTIG, LLC, served as the sole book-running manager for the offering.

The Securities and Exchange Commission (SEC) declared the registration statement relating to these securities effective on December 4, 2025. The offering was made only through a prospectus, which can be obtained by contacting BTIG, LLC at 65 East 55th Street, New York, NY 10022, via email at ProspectusDelivery@btig.com, or by visiting the SEC’s website.

The company will prioritize businesses in the international energy supply chain and critical minerals sectors, including their related infrastructure in its search for attractive merger candidates.

Media Contact:
Company: Leapfrog Acquisition Corp
Contact: Media Team
Telephone: +1-201-379-4200
Email: info@leapfrogspac.com
LinkedIn: https://www.linkedin.com/company/leapfrog-acquisition-corporation

Source: Leapfrog Acquisition Corp

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.